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SUMMARY
Sustained research efforts over the last 50 years have
revealed a considerable amount of information about immu-
nity to taeniid cestode infections in the parasites’ intermedi-
ate hosts. As a product of this research, a series of effective
recombinant vaccines have been developed which have no
parallel in any other group of parasitic organisms. There
are, however, many important aspects relating to immunity
that remain to be elucidated. Some concepts have come to
be firmly held as facts and yet the supportive data are either
conflicting or unconfirmed. This review considers the phe-
nomenon of immunity to re-infection with taeniid cestodes in
their intermediate hosts, examining carefully the nature of
the evidence that is available to support conclusions that
have been drawn in this area.
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INTRODUCTION
Taeniid cestodes are unique among the helminth parasites
in that protective immune responses can be readily dem-
onstrated in the parasites’ intermediate hosts. In retro-
spect, it seems unsurprising that one of the first clear
demonstrations of the induction of immunity to a meta-
zoan parasite was achieved with a taeniid cestode (1). A
great deal is now understood about the nature of the
protective immune responses to taeniid cestodes, stemming
initially from the work of Harry M. Miller in the 1930s
and developed through seminal contributions by Michael
A. Gemmell, David D. Heath, Jeffrey F. Williams,
Graham F. Mitchell and Michael D. Rickard (2). An
understanding of the nature of the host-protective
responses (3) has been harnessed over the past 20 years to
develop extraordinarily effective recombinant vaccines.
These seem likely to play a future role as new tools for
the control of hydatid disease and cysticercosis caused by
Taenia solium (4,5).
Although much is understood about the nature of the
protective immune responses to taeniid cestodes, many
aspects still remain to be clarified and require further
investigation to confirm concepts that have come to be
considered as being well-established facts, while the pub-
lished data may be equivocal. Here, the concept of immu-
nity to re-infection with taeniid cestode parasites in their
intermediate hosts is examined with a view to dissecting
aspects for which there is good, reproducible evidence and
differentiating these from aspects which would be better
regarded as hypotheses in need of further experimental
assessment.
CONCOMITANT IMMUNITY
One of the hallmarks of the immunology of taeniid ces-
tode infection in their intermediate hosts is that infected
hosts are immune to re-infection. This situation is some-
times referred to as concomitant immunity, a term
adopted in the 1980s from the field of tumour immunol-
ogy (6). In this situation, an infected animal is immune to
re-infection, while at the same time parasites from the
initial infection remain unaffected.
Immunity to re-infection has been demonstrated experi-
mentally in many taeniid parasite⁄host systems, however,
it seems likely that this immunity is not associated with
previous infection per se but rather to previous exposure
to host-protective antigens unique to the oncosphere and
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provided data that can be used to directly support this
hypothesis. Data that are available suggest that immunity
to ‘re-infection’ may arise in a situation where a host is
exposed to taeniid eggs even if this does not lead to the
establishment of an on-going viable infection and that
immunity wanes in the continued presence of viable met-
acestodes. Hence, immunity to re-infection in the interme-
diate hosts of taeniid cestodes may be a reflection of the
host’s exposure to antigens associated with the early
invading parasite, irrespective of whether a (continuing)
infection is established by the initial exposure to infective
parasites.
Harry M. Miller (7) credits Vogel (8) with the first
description of immunity to superinfection in the interme-
diate hosts of Taenia taeniaeformis, however, it was Miller
himself who clearly demonstrated the phenomenon and
defined many of its characteristics. While working on stud-
ies investigating whether it was possible to stimulate artifi-
cial immunity to an experimental challenge infection with
eggs of T. taeniaeformis in rats, Miller (7,9) noticed that
occasionally his experimental rats failed to become
infected after he administered an oral challenge infection
with eggs. At post-mortem, these animals were found to
harbour large, mature strobilocerci of T. taeniaeformis,
indicating that the animals had been exposed to infection
with the parasite while they were with his animal supplier.
Miller undertook experiments to test the hypothesis that
infected animals were immune to re-infection and con-
firmed this unequivocally (7). Na ve rats also could be
protected against infection with T. taeniaeformis by inject-
ing serum collected from infected animals (10). Recipients
of immune serum were only protected if the serum was
given prior to 8 days after the initiation of an infection
(11), potency of the serum in transferring passive protec-
tion was related to the degree of infection seen in the
serum donors (12) and the effectiveness of the serum to
transfer protection persisted in donors for at least
2 months after the removal of the larvae from the serum
donors via laparotomy (13). Resistance to superinfection
was subsequently shown to occur in many different hosts
of many species of cestode [see reviews by Lloyd (14),
Williams (15) and Rickard and Williams (3)]. Michael
Gemmell elevated experiments on immunity to re-infection
with taeniid cestodes in sheep to something of an art
form. Extending the initial discovery by Froyd and Round
(16) that taeniid cestodeswould develop at an aberrant tissue
site in the host following the injection of activated onco-
spheres, Gemmell applied this technique to differentiate
between parasites arising from a primary infection and
those arising from a secondary infection. He demonstrated
high levels of protection following an initial exposure to
parasites of the homologous species and partial protection
when sheep were challenged with a heterologous species of
taeniid cestode (17–19).
We can deduce from this information that concomitant
immunity can certainly be demonstrated in the intermedi-
ate hosts of many species of taeniid cestode. What is not
so clear are the parameters surrounding this phenomenon,
particularly those that would impact on the phenomenon
in naturally infected animals. This is not something of aca-
demic interest alone. Computer models are being adopted
to assist with predicting the impact of various disease con-
trol options for hydatid disease (20–22) and cysticercosis
(20,23,24). One of the parameters incorporated into such
models is the impact of immunity on the accumulation of
an increased parasite burden in older animals as a result
of re-exposure. While the evidence is clear that experimen-
tal exposure of hosts to infection leads to immunity to a
subsequent experimental challenge infection, it is not clear
what level of initial infection leads to immunity nor the
duration that immunity persists. It is also not clear
whether the continued persistence of viable parasites from
an initial infection maintains immunity to re-infection.
Two ‘phases’ of resistance to infection with taeniid met-
acestodes are recognized: the pre-encystment phase and
the post-encystment phase. This understanding arose ini-
tially from experiments on T. taeniaeformis in rats where
‘early’ and ‘late’ immunity were recognized and concluded
to operate independently (25,26). In sheep, Gemmell
(17,18) considered the early phase of immunity to be act-
ing at the level of the intestine (18), making this differenti-
ation on the basis of whether there were no detectable
lesions from parasites in a challenge infection (early, intes-
tinal or pre-encystment immunity) as distinct from there
being nonviable lesions at the parasites’ site of election
(late or post-encystment immunity). Rickard and Williams
(3) made the important observation that both of these
forms of immunity are acting on the establishing parasites.
While the phenomenon has been confirmed more recently
(27) the immunological basis for the distinction between
early and late immunity remains unclear and it is possible
that the distinction relates only to the degree of damage
inflicted on the early developing parasite, with lesser dam-
age allowing the parasites to survive long enough to create
a macroscopically visible lesion (3). A role for immune
mechanisms acting within the gut is also possible and
could contribute to ‘early’ immunity. Gemmell’s view that
the absence of a lesion was associated with immunity act-
ing at the intestinal level does not necessarily follow
because the death of a 25-lm oncosphere in the tissues
would be unlikely to lead to a macroscopically visible
lesion in the tissues which could be found some weeks
later when the animals were necropsied. This has been
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been shown to reach the liver in passively immunized
hosts (28) but are rapidly killed there; such animals typi-
cally show no trace of any liver lesions when necropsied
several weeks after the challenge infection (10,26,29–31).
The identification of highly protective recombinant anti-
gens from several taeniid species provides some insight
into the susceptibility of different lifecycle stages to immu-
nological attack and the ability of different lifecycle stages
to maintain immunity by evoking immune responses to
these antigens in infected animals. All host-protective anti-
gens that have been defined have been found to be
restricted to expression in the oncosphere or very early
developmental phases of the parasites (32). Hence,
immune responses to these antigens would be expected to
have no effect on mature metacestodes and mature metac-
estodes could not maintain protection in infected animals
by continuing to stimulate immune responses to these anti-
gens. There is ample evidence to indicate that extracts
from metacestodes contain host-protective antigens [see
(1), for example], and immunization with these antigens
has its effect against a challenge infection in a similar way
to the effects of vaccinating with oncosphere antigens i.e
against the oncosphere or early developing (immature)
metacestode. While immunization with metacestode anti-
gens can have host-protective effects, it is unclear whether
the existence of mature living metacestodes in a host is
sufficient to maintain concomitant immunity.
The question remains, not whether it is possible to dem-
onstrate concomitant immunity but whether concomitant
immunity is associated with prior infection per se and also
how much ‘infection’ leads to immunity. Is infection with
a single parasite sufficient to establish immunity or to
maintain immunity? Knowledge in these areas would be
useful to provide accurate information for use in mathe-
matically modelling cestode infections in conditions of dif-
ferent disease endemicity. However, there is very little data
on these subjects and what there is suggests that concomi-
tant immunity in cestode infections may be more a labora-
tory artefact than a practical reality in many naturally
infected hosts.
There are few data available on what the minimum
number of parasites is that a taeniid host must be exposed
to generate immunity to further infection. It is important
to make a distinction between the number of parasites
present in the tissues of an infected host from the number
of oncospheres that an animal has been exposed to. Typi-
cally, a minority of the parasites that are given in an
experimental infection actually establish in a na ve, suscep-
tible host. What happens to the other oncospheres that do
not successfully establish is not known, nor is it known
whether these oncospheres have the potential to contribute
to the stimulation of a protective anti-oncosphere immune
response. No experiments have been performed examining
immunity arising following infection with a single egg.
Miller’s observations that some of the rats supplied to him
had a single mature metacestode and were refractory to
his experimental infection (7,9), suggests that perhaps only
a single metacestode of this species may be sufficient to
stimulate and maintain concomitant immunity. Miller
noted that often these same rats showed nonviable liver
lesions indicating that the animals had indeed been
exposed to more than a single oncosphere. The experi-
ments of Miller (33) and Musoke and Williams (34) on
transplantation of T. taeniaeformis metacestodes may be
informative in this respect. Rats can be protected against a
challenge infection by surgical implantation of mature cys-
ticerci intraperitoneally. Transplantation of both live cysti-
cerci as well as the same number of nonviable cysticerci
(killed by freeze⁄thawing prior to transplantation) induced
protection, although the level of protection was superior
in the case of live cysticerci (34). It is difficult to interpret
these studies as being the equivalent to the presence of a
small number of mature parasites in the animals because
the parasites were placed free in the peritoneal cavity
rather than being enclosed within the capsule which nor-
mally surrounds the parasite in the liver tissue. Also the
value of this as a model for other Taenia species in this
respect can be questioned because the presence of a single
large strobilocercus in a small host animal would be the
weight equivalent of many thousands of cysticerci of Tae-
nia ovis, Taenia solium or Taenia saginata in sheep, pigs or
cattle, respectively. However, Miller’s work with the T. tae-
niaeformis⁄rat model does provide further clues as to the
level of infection required to induce concomitant immu-
nity. Miller and Gardiner (12) found that serum taken
from rats with light, long-standing viable infections were
either unable to transfer protection to na ve recipients or
were poorly protective in comparison to serum taken from
donors within weeks of an experimental infection; serum
taken from rats that developed no viable parasites was,
nevertheless, able to transfer protection and serum from
donors with only light infections were substantially less
effective in transferring protection than was serum from
more heavily infected animals. Kerr (35) also found that
rabbits which failed to develop viable parasites from a pri-
mary infection with Taenia pisiformis were nevertheless
immune, or relatively immune, to superinfection.
Other data that pertains to the extent and duration of
concomitant immunity comes from the work of Heath and
his colleagues with T. pisiformis in rabbits and Gemmell
and his colleagues with Taenia hydatigena in sheep. Heath
and Chevis (36) undertook an experiment specifically to
determine the duration of concomitant immunity arising
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rabbits and also to determine whether maintenance of this
immunity was dependent upon the continued presence of
viable parasites from the initial infection. Three groups of
24 rabbits were used, two groups being given an infection
with 1000 T. pisiformis eggs. One group of infected ani-
mals was administered mebendazole between 6–8 weeks
post-infection sufficient to kill all the metacestodes. From
9 weeks post-infection and for a further 11 months, two
animals from each group were given a challenge infection
with T. pisiformis eggs and these animals necropsied at a
time which allowed differentiation of parasites from the
recent infection (migrating in the liver) from those which
established from the initial infection (in the peritoneal cav-
ity). Although a small number of the animals which had
received the initial infection did show the development of
some larvae from the secondary infection after a period of
5 months, the majority remained immune to superinfec-
tion at least until approximately 13 months after the initial
infection. This was the case both for the animals which
maintained viable parasites from the initial infection as
well as animals in which all the parasites from the initial
infection had been killed by drug treatment 6–8 weeks
post-infection.
As mentioned previously, we now know that some or all
of the anti-oncosphere immune responses are elicited by
antigens that are uniquely expressed by the oncosphere. In
the experiments undertaken by Heath and Chevis (36), we
are unable to differentiate whether the immunity that per-
sisted for 14 months after the initial infection was the
result of the exposure to oncosphere antigens or whether
immunity could have been maintained for the lifetime of
the infected rabbits as a result of the continued presence
of viable metacestodes. It would have been interesting had
the animals in this experiment been challenged at longer
intervals sufficient to differentiate more effectively between
waning anti-oncosphere responses and protective responses
maintained by the metacestodes. Heath (37) surgically
transplanted T. pisiformis larvae of different stages of
maturity intraperitoneally into na ve rabbits and noted
that larvae up to the age of 15 days were able to confer
absolute resistance to a challenge infection. However, after
this time the ability of more mature larvae to stimulate
protection waned and implantation of mature cysticerci
failed to stimulate any protection. This study provides the
most convincing evidence that infection with taeniid ces-
todes per se does not lead to a state of concomitant immu-
nity. Rather, exposure to the early developing parasite
stimulates a transient protection against the survival of
parasites from a subsequent exposure to eggs.
It could be argued that even brief exposure of a host to
the early stages of parasite development, even if this does
not lead to a mature, continuing infection, is sufficient to
come under the definition of ‘prior infection’. This issue is
not semantic. The following would have implications for
understanding the extent to which immunity to re-infection
impacts on the natural regulation in transmission of taeniid
cestodes: duration of protection following an initial infec-
tion; whether protection occurs in all infected hosts or
whether there is a threshold of initial exposure below which
no effective immunity to re-infection occurs and whether
natural levels of exposure to taeniid eggs in an endemic or
hyperendemic environment is sufficient to maintain immu-
nity. Unfortunately, there is very little direct, good quality
evidence around any of these important issues.
The bulk of available evidence suggests that experimen-
tal exposure of the intermediate hosts of taeniid cestodes
to parasite eggs, even if that leads to the early stage of
host invasion but not persisting infections, nevertheless
can induce protection against a subsequent challenge
infection. Evidence from T. taeniaeformis in rats has been
referred to above and Dow et al. (38) and Urquhart et al.
(39) induced protection in mice and cattle following their
exposure to radiation attenuated eggs of T. taeniaeformis
and T. saginata, respectively. One dissenting finding is that
of Coman and Rickard (40) who found that rabbits
exposed to ‘senescent’ eggs of T. pisiformis, which were
able to develop only to the point of producing nonviable
liver lesions, were not immune to a subsequent challenge
infection. This experiment, however, did not include a
positive control group and a number of the experimental
animals died of a ‘mucoid enteritis-like’ syndrome, and
hence, the authors indicate that they could not exclude
immunosuppression in the other experimental animals
interfering with their ability to develop a protective
immune response after the initial exposure to eggs.
Results of experimental investigations on immunity to
superinfection in domestic animals confirm the develop-
ment of immunity to re-infection after an initial experi-
mental infection. Penfold (41,42) undertook a series of
small but well-controlled experiments providing evidence
that cattle which had received a large experimental infec-
tion with T. saginata (400 000 eggs) were immune to a
subsequent challenge infection for as long as 18 months
after the initial infection. Urquhart (43) found that young
calves raised in conditions where many animals became
naturally exposed to T. saginata eggs within the first day
after birth were resistant to a later experimental challenge
infection. This was interpreted as being because of the ani-
mals having previous exposure to the parasite; however,
the data were confounded by a proportion of the animals
that were resistant to the challenge infection showing no
sign of pre-existing infection. Convincing evidence that
cattle exposed to T. saginata eggs become resistant to a
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whose data are discussed in more detail below.
Sweatman (45) showed conclusively that sheep which
had been given an initial experimental infection with
T. hydatigena were solidly immune to a challenge infection
with the parasite given 7 weeks after the initial infection.
Injection of activated T. hydatigena oncospheres, and the
subsequent growth of the parasites around the site of
injection, leads to immunity to a subsequent oral infection
(46). Heath et al. (47) used a combination of oral infection
and injections of activated oncospheres and demonstrated
that this procedure resulted in total resistance of sheep to
challenge infection with homologous parasites: T. hydati-
gena, T. ovis or Echinococcus granulosus.
Gemmell (48) undertook experiments designed to deter-
mine what minimum number of parasites in a primary
infection were required to induce immunity against subse-
quent infection. Sheep were dosed with either 10, 100 or
1000 eggs of T. hydatigena or T. ovis or were given ten con-
secutive doses of either 10 or 100 eggs at weekly intervals.
The intention was to compare the number of parasites seen
at necropsy in those given multiple divided doses and to
judge from that number how many doses successfully
established as viable parasites prior to the animals becom-
ing immune and accumulating no further cysts. The results
have been interpreted to suggest that as few as 10 eggs may
be sufficient to achieve immunity to subsequent infections
(48–50). However, the reliability of even a single infection
with 10, 100 or 1000 parasites to produce any detectable
infection (viable or otherwise) in the experimental animals
was so poor that it makes interpretation of the data diffi-
cult. Gemmell and Johnson (50) provide statistical analysis
of the data described in Gemmell’s earlier paper (48) and
the results were mixed; sheep receiving 1000 eggs of T. hyd-
atigena in a single dose had numbers of parasites that were
not significantly different from the numbers seen in sheep
given ten doses of 100 eggs.
Flisser et al. (51) attempted to summarize the results of
many publications using an index based on the proportion
of the eggs in a challenge infection that were infective and
comparing ‘normal’ and ‘immune’ hosts. These data
included studies on taeniid species infecting rodents, rab-
bits, pigs, sheep and cattle. Eggs established more effi-
ciently in normal hosts, however, it is unclear what
situations were amalgamated under the term ‘immune’
and hence it is difficult to interpret the tabulated data.
Is immunity maintained only with continued exposure to
eggs?
One of the commonly accepted beliefs arising from studies
on resistance to superinfection with taeniid cestodes is that
animals infected early in life gain life-long immunity pro-
vided they are frequently re-exposed to parasite eggs.
Much of the data which supports this hypothesis comes
from failed attempts to experimentally infect animals
derived from a population of animals some of which have
a naturally acquired infection. These data are unreliable
and evidence to support the existence of prior infection in
resistant animals may not correlate with resistance to the
challenge infection (43). It was mentioned earlier that rats
may develop immunity to a challenge infection even in cir-
cumstances where the initial exposure to eggs did not
result in the establishment of any viable larvae. A similar
phenomenon was also shown to be true for T. hydatigena
or T. ovis in sheep (52). Hence, a failure to detect viable
parasites in animals raised in conditions likely to lead to
natural exposure to the parasite, and which were found to
be resistant to an experimental infection without evidence
confirming the presence of a pre-existing infection, cannot
be taken as evidence to reject the hypothesis that immu-
nity in these animals was the result of prior exposure to
the parasite. There is anecdotal evidence on the resistance
of animals naturally exposed to taeniid cestodes to an
experimental infection, but there are few data available to
suggest how frequently this exposure needs to be, nor
what quantity of eggs is required, to maintain the immune
status. Gallie and Sewell (44) investigated these issues in
relation to T. saginata infection in cattle. Three groups of
cattle were used. Two groups received 10 000 eggs at 2–
3 days of age. One of these groups also received repeated
doses of 500 eggs at weekly intervals for the following
12 months. At 12 months of age, all three groups were
given a challenge infection with 50 000 eggs and the ani-
mals subjected to necropsy after the challenge infection at
a time when it would be possible to distinguish between
parasites persisting from earlier infections and the more
recent, large challenge infection. The results of the trial
are shown in Table 1. There were slightly more parasites
in the animals that received weekly exposures to the para-
site, but the difference was not statistically significant in
comparison with animals only given 10 000 eggs at 2–
3 days of age. Those animals that received only the initial
exposure to T. saginata were highly susceptible to the chal-
lenge infection. Of these five animals, two contained
mature viable parasites from the initial infection, which
clearly did not prevent infection from the challenge at
12 months of age. Those animals that had received infec-
tions at 2–3 days of age, as well as further weekly infec-
tions over the 12-month period, were completely resistant
to the establishment of any viable parasites from the chal-
lenge infection. Four of the five animals were completely
resistant to the challenge infection, while the remaining
animal developed only eight nonviable lesions. These data
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the notion that a trickle exposure to eggs can maintain
immunity. In the group given the trickle infection, 2 of the
5 animals had no viable, mature parasites present at the
time of necropsy and yet they were resistant to the chal-
lenge infection, confirming data from T. taeniaeformis and
T. hydatigena, that the continued presence of viable metac-
estodes is not requisite for the establishment of a state of
immunity to re-infection.
The following issues concerning concomitant immunity in
the intermediate hosts of taeniid cestode parasites can be
regarded as having been clearly established:
1 Following a relatively large, experimental infection,
hosts develop a high level of resistance to re-infection.
2 The development of immunity relates to the exposure of
the host to early developing parasites.
3 Induction of immunity is not dependent upon the estab-
lishment of viable, mature parasites from the initial
exposure to parasite eggs.
4 Immunity wanes irrespective of the continued presence
of mature metacestodes.
5 Immunity can be maintained experimentally by
repeated, frequent re-exposure to parasite eggs.
The following issues are not well established:
1 The minimum infecting dose of eggs required to induce
protective immunity.
2 The duration of immunity to re-infection in the absence
of further exposure to eggs.
3 The minimum number of eggs required, or the fre-
quency required, for repeated egg exposure to maintain
protection.
4 The extent to which the level of exposure to taeniid ces-
tode eggs that occurs in normal endemic situations is
sufficient to develop immunity and serve to prevent the
accumulation of further infection.
5 Whether ‘early’ and ‘late’ immunity are associated with
different parasite antigens.
An understanding of the dynamics of immunity to
re-infection with taeniid cestodes would aid in making
accurate predictions of what could be expected to occur in
various endemic situations.
Evidence from age-related differences in infection preva-
lence and intensity
There are relatively few studies of the intensity of taeniid
cestode infections in naturally exposed animals that are
not compromised by the methodologies used. Gemmell
(53) examined damage to livers caused by T. hydatigena in
sheep of different ages and stated in conclusion ‘‘it is not
unreasonable to suggest that in the field the primary infes-
tation of cysticerci results in an absolute or at least a rela-
tive immunity against later infestations of T. hydatigena in
New Zealand sheep’’. The study assessed liver damage and
did not enumerate the number of parasites in each animal.
Surveys of E. granulosus infection in domestic animals
have identified an increasing prevalence in successive age
classes (54–58). However, this cannot in itself be used as
an indication of a lack of immunity. Some studies either
did not undertake detailed examination of the organs
affected (59) or it is not entirely clear what procedures
were used to identify hydatid cysts (56,57). There are sub-
stantial difficulties in identifying small hydatid cysts which
can limit detection in younger animals, depending on the
procedures used (59,60). However some studies have been
carried out which could have been expected to identify
small, younger hydatid cysts accurately, and these studies
have identified an increase in the prevalence of infection
(55,58,61). More importantly from the point of view of
immunity affecting disease epidemiology is that Lamar
et al. (58) and Dueger et al. (61) found that sheep in ende-
Table 1 Number of cysts found in calves following challenge with 50 000 eggs of Taenia saginata. Reproduced from Gallie and Sewell (44)
Group No. Infection schedule
No. of cysts in carcase
Prechallenge cysts
Cysts derived from
challenge infection Alive Dead
1 Repeated infections from 2 to 3 days
old until challenge at 12 months.
20 € 27 7 € 6 8 dead cysts in one animal only.
2 Single infection at 2–3 days old
plus challenge at 12 months.
2 € 3 5 € 5 6080 € 2969
3 Challenge at 12 months only. – – 8177 € 3015
The figures shown are means € standard deviations. The difference between the numbers of the older cysts in Groups 1 and 2 or between
the number of cysts derived from the challenge infection in Groups 2 and 3 were not statistically significant.
Volume 32, Number 8, August 2010 Concomitant immunity in taeniid cestode infections
  2010 Blackwell Publishing Ltd, Parasite Immunology, 32, 582–589 587mic areas had an increasing intensity of infection with
increasing age, with animals 1–2 years of age having on
average about two cysts while animals ‡5 years of age had
about 8–10 cysts. This is not evidence against the possibil-
ity that immunity is limiting the accumulation of new cysts
in re-exposed animals, but it does provide evidence to sug-
gest that immunity does not prevent the establishment of
new cysts in already infected animals in a natural field
situation.
CONCLUDING REMARKS
Although much has been discovered in relation to immu-
nity to taeniid cestode infections, there is clearly much still
to be learnt. Aspects such as the duration of immunity fol-
lowing initial infections with different numbers of para-
sites, what frequency and what minimum number of
parasites is required to maintain immunity, and whether
immunity to vaccines is boosted by natural exposure to
oncospheres, are important issues for future research. Such
information would be valuable to assist with preparation
of accurate models of disease transmission, particularly as
they apply to the practical use of vaccines.
A number of other issues pertaining to immunity to tae-
niid cestode infections are the subject of conflicting data or
opinions, and warrant careful consideration. These include,
among others, the strength of the evidence to support the
existence of host protective immune responses in definitive
hosts, the immunogenicity of oncosphere penetration gland
secretions and the role of these glands in assisting onco-
spheres penetrate the host intestine, and the usefulness of
Taenia crassiceps as a model for Taenia solium vaccine devel-
opment and the S3Pvac vaccine developed using this model.
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